-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O3.6 905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Outcomes Research Real World Data Healthcare Disparities

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Follicular Lymphoma, multiple myeloma, Diseases, CLL, Lymphoma (any), Marginal Zone Lymphoma, Hodgkin Lymphoma, Elderly, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, DLBCL, Hemoglobinopathies, immune cells, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement
Saturday, December 5, 2020: 12:00 PM-1:30 PM
Moderators:
Lena E. Winestone, MD, MSHP, UCSF, University of California San Francisco, Benioff Children's Hospital and Narendranath Epperla, MD, MS, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Disclosures:
Epperla: Verastem Oncology: Speakers Bureau; Beigene: Speakers Bureau; Pharmacyclics: Honoraria.
12:00 PM

Augusta Eduafo, DO1*, Leland Metheny III, MD2, James Driscoll3*, Benjamin K. Tomlinson, MD2, Kirsten M Boughan, DO2, Molly M Gallogly, MD, PhD2, Marcos de Lima, MD2 and Ehsan Malek, MD4

1Internal Medicine Department, St. John Medical Center, Cleveland, OH
2Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
3Case Western Reserve University, Cleveland, OH
4Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

12:15 PM

John L Vaughn, MD1, Ana C. Xavier, MD2 and Narendranath Epperla, MD, MS3

1Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
2University of Alabama at Birmingham, Vestavia Hills, AL
3Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

12:30 PM

Madison H. Williams, MD1,2, Ryan A. Williams, MD2,3, Jean Pierre Blaize, MD2,3, Snegha Ananth, MBBS2,3, David Gregorio, DO2,3, Gerardo Manuel Rosas, MD2,3*, Michael M. Song, MD, PhD, PharmD2,3, Brian Warnecke, DO2,3*, Abhishek Pandya, DO2,3, Lakene Raissa Djoufack Djoumessi, MD2,3*, Vivian Dee, NP2*, Phillip Nazarewicz2*, Kathleen Franklin2*, Juan J. Toro, MD, MS2*, Michael Mader, MS2* and Zohra Nooruddin, MD2

1University of Texas Health Science Center At San Antonio, San Antonio, TX
2South Texas Veterans Health Care System, San Antonio, TX
3University of Texas Health Science Center San Antonio, San Antonio, TX

12:45 PM

Saqib Abbasi, MD1, Brian McClune2*, Al-Ola Abdallah, MD3, Leyla Shune, MD3 and Ghulam Rehman Mohyuddin4*

1Kansas University Medical Center, Kansas City, KS
2University of Utah, Salt Lake City
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
4Kansas University Medical Center, Kansas City

1:00 PM

Siddharth Bhesania1*, Silpa Anand2*, Tanveer Dabria3*, Swathi Veliginti4*, Sahithi Nadella5*, Nikhil Kumar Kotla6*, Pritika Manaktala, MD7*, Chanoa Medina, MD1*, Janki Bhesania, MD8*, Achint Patel, MD, MPH9*, Angelica Singh, MD1*, Parag Mehta, MD1* and Eshan Patel, MD1

1NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY
2Swedish Covenant Hospital, Chicago, IL
3Gian Sagar Medical College & Hospital, Rajpura, India
4Shadan Institute Of Medical Sciences, Hyderabad, India
5Bhaskar Medical College & General Hospital, Hyderabad, India
6Kamineni Institute of Medical Sciences, Narketpally, India
7Canton Medical Education Foundation, Canton, OH
8Independent Researcher, Brooklyn
9Independent Researcher, Sayre, PA

1:15 PM

Smith Giri, MD1, Susan Bal, MD, MBBS2, Kelly N. Godby, MD1*, Joshua Richman, MD, PhD3*, Adam J Olszewski, MD4, Grant R Williams5*, Luciano J. Costa, MD, PhD6 and Smita Bhatia, MD, MPH5

1University of Alabama at Birmingham, Birmingham, AL
2O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
3Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL
4Brown University, Providence, RI
5Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
6Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL

*signifies non-member of ASH